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Abstract 
Introduction:After uncomplicated cataract surgery, macular oedema has been suggested as the most common cause 
of visual deterioration and there is increased incidence of Macular Oedema (ME) in patients with diabetic 
retinopathy (DR). Further, ME has been seen to worsen after eye surgery in patients with pre-operative DME. 
Objective: To evaluate and compare the macular thickness changes after uncomplicated phacoemulsification in type 
2 diabetes mellitus patients with Non Proliferative DR using Optical Coherence Tomography (OCT).Methods: The 
study was a hospital based prospective observational study conducted on 75 eyes of type 2 diabetes mellitus with 
NPDR who were diagnosed with cataract and underwent uncomplicated phacoemulsification. In all study subjects 
macular thickness using Cirrus High Definition (HD) OCT and Best Corrected Visual Acuity (BCVA) in Logarithm 
of Minimum Angle of Resolution (Log MAR) was recorded preoperatively and postoperatively at Day One, two 
weeks, four weeks, Six weeks and eight weeks to see changes in the macular thickness.Results: Out of 75 eyes 
macular edema was developed in 3 (4.0%) eye postoperatively. All central as well as parafoveal thickness increased 
significantly during our follow up time.Conclusion: Increase in central as well as parafoveal macular thickness was 
observed in subjects with NPDR after phacoemulsification. In few patients macular edema was also observed during 
our follow up period. OCT is a noninvasive, rapid, and useful tool in detecting and monitoring CME in post cataract 
surgery patients but longer follow up is needed to assess the risk of Cystoid macular edema (CSME) progression 
after cataract surgery and to see whether increase in central and parafoveal thickness after phacoemulsification is 
temporary or permanent. 
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Introduction 
 
Diabetic retinopathy may be the most common 
microvascular complication of diabetes. Retinopathy 
develops in one every four diabetics which is major 
cause of visual impairment. Prevalence of retinopathy 
in diabetics is 25%.[1]  
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It has been estimated that 28.85% of all diabetics will 
have some form of retinopathy irrespective of severity 
and duration of diabetes. Diabetic Retinopathy is one 
of the major tragedies of ophthalmology in our present 
generation, effecting the young as well as the aged, and 
relatively untreatable, chronic and progressive in its 
course and leading to blindness in a distressing 
percentage of cases.[2]After uncomplicated cataract 
surgery, macular oedema has been suggested as the 
most common cause of visual deterioration.[3,4] and 
there is increased incidence of ME in patients with 
diabetic retinopathy (DR). Further, ME has been seen 
to worsen after eye surgery in patients with pre-
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operative DME.[5,6] However, qualitative as well as 
quantitative parameters of macula can now be attained 
better with the availability OCT and the relationship 
between macular status pre and post cataract surgery 
can be explored in patients with diabetes.[7-9]Previous 
studies on patients with diabetes undergoing cataract 
removal using intracapsular and extracapsular cataract 
extraction techniques suggested that for incidence of 
macular edema (ME) or worsening of diabetic 
retinopathy, cataract surgery was a risk factor.[10-12] 
Some reports suggested that in people with diabetes 
macular edema after cataract surgery may occur 
predominantly in people with concurrent pre-existing 
diabetic macular edema (DME) involving the centre of 
the macula. However other reports indicate that pre-
existing DME is not needed for ME to occur post-
operatively.[3] However, these studies were completed 
prior to the availability of optical coherence 
tomography (OCT) technology. In this study, we tried 
to assess the changes of macular thickness in patients 
with diabetes having non-proliferative retinopathy after 
phacoemulsification using OCT which helped us to 
estimate the ME incidence post-surgery in diabetic 
eyes in our institution.  
 
Subjects and Methods 
 
Study design, settings and participants: It was a 
hospital based prospective observational study 
conducted over a period of 18 months from March 
2018 to August 2019 in ophthalmology department of a 
tertiary care teaching hospital in Southern Rajasthan, 
India. 75 eyes of type 2 diabetes mellitus patients age 
>40 years with NPDR, BP≤ 150/90mmHg and with >5 
years of diabetes duration who were diagnosed with 
cataract and underwent uncomplicated phaco-
emulsification and posterior chamber intraocular lens 
implantation at our departmentconstituted the study 
population. Eyes with high myopia, neuro-ophthalmic 
anomalies, advanced cataract or hazy media, history of 
ocular diseases like glaucoma, uveitis, any ocular 
surgeries, patient with complications of diabetes like 
severe diabetic nephropathy, uncontrolled hypertension 
or CVS disease, previous medical treatment of retinal 
disorder or any therapy that affect retinal edema, 
patients with refractive errors of more than +5 Diopters 
spherical, or -8 Diopters spherical, IOP >21 mmHg as 
determined by Goldmannapplanation tonometry or 
patients with pre-existing Macular edema were 
excluded from the study. 
Data collection 
After taking written informed consent patients with 
inclusion criteria were subjected to detailed history 
regarding duration of diabetes and treatment taken, 
history of hypertension and any other systemic and 
ocular.All patients underwent preoperative 
ophthalmological examination which included: 
 UCVA (uncorrected visual acuity) & BCVA using 
Snellen’s chart and converted to logarithm of the 
minimal angle of resolution (LogMAR) scale for 
analysis. Slit Lamp assisted  Biomicroscopy of anterior 
segment 
 Slit Lamp assisted Biomicroscopy of posterior segment 
with+90D/+78D 
 Intraocular pressure measurement (IOP) with 
Applanation Tonometry 
 Intraocular Lens (IOL) Power was calculated using 
Keratometer& A-scan 
 Macular thickness was recorded using Cirrus HD-
OCT(Carl Zeiss/Meditec) 
In those patients in whom preoperative thickness value 
was not possible because of the presence of significant 
media opacity interfering with good quality OCT scan, 
macular thickness on the first postoperative day was 
taken as baseline value in our study as no significant 
change in the foveal and perifoveal thickness values 
occurs on the first postoperative day[13,14].Pre-
operative mydriasis was done byEye drops 
Tropicamide 1% + Phenylephrine 2.5% while 8-10 ml 
Peribulbaraneasthesia (eye drops xylocaine 2% + 
adrenaline1:200000 + eye drops bupivacaine 0.5%) 
was given to the patients before the surgery. 
Phacoemulsification 
A 2.8 mm superior clear corneal incision was made 
using a 2.8 mm keratome. A paracentesis incision of 1 
mm was made 90° apart with a 15° knife. After the 
capsulorrhexis, hydrodissection and hydrodelineation 
followed by nucleus rotation was done. A 
phacoemulsification tip was used to emulsify the 
cataract using direct chopping or divide and conquer 
technique. After emulsification of nuclear fragments, 
irrigation aspiration of residual cortical matter was 
done. A posterior chamber intraocular lens was put 
inside the capsular bag. After this the removal of the 
ophthalmic viscoelastic material was done and finally 
the incision was hydrated using a 30-gauge cannula. 
Hydration of the cornea was maintained throughout the 
surgery. In the end subconjuctival injection of 
Gentamycin (40mg/ml) with Dexamethasone (4mg/ml) 
was given in the operated eye. All subjects were 
followed up on postoperative Day 1, 2 Weeks, 4 
Weeks, 6 Weeks and 8 weeks. 
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Fig 1:Baseline and outcome diabetic and cystoid macula oedema definitions[3] 
 
Statistical analysis 
The collected data were transformed into variables, 
coded and entered in Microsoft Excel. Data were 
analyzed and statistically evaluated using SPSS-PC-20 
version.Quantitative data was expressed in mean, 
standard deviation while qualitative data were 
expressed in percentage. Comparison between values 
measured preoperativelyand postoperatively in the 
same group was carriedout using the paired t‑test or 
Wilcoxon sign rank test. ‘P’ value less than 0.05 was 
considered statistically significant 
Ethical issues 
All participants were explained about the purpose of 
the study. Confidentiality was assured to them along 
with informed written consent. The study was 
approved by the Institutional Ethical Committee. 
 
 
Observations & Results 
 
Two-third of the study subjects were between the age 
group of 51-70 years. The mean ± SD age was 58.41± 
8.92 years in diabetes subjects.Out of 75 subjects, there 
were 36 female patients and 39 male patients showing 
almost equal distribution.sixty-three cases (84%) had 
mild and 12 cases (16%) had moderate NPDR. None of 
the subject was having severe NPDR. Out of 75 study 
subjects 52 (69.3%) patients had diabetes form 6-10 
years while 22 (29.3%) patients had diabetes history 
between 11-15 years. One patients informed regarding 
history of diabetes since >15 years. 3 (4.0%) study 
subjects developed macular oedema after 
phacoemulsification till 8 weeks follow up. All central 
as well parafoveal thickness showed significant 
increase at 2,4,6 and 8 weeks follow-up compared with 
baseline measurements (<0.001). (Table 2). 
 
Table 1: Central Macular thickness before surgery and till 8 weeks follow-up in study subjects  
 CMT SMT NMT IMT TMT 
Baseline 239.49±15.24 309.15±13.81 308.01±37.53 307.71±13.59 301.31±11.86 
At 2 weeks 249.20±18.25 316.03±14.21 318.65±15.15 316.56±15.01 313.39±12.07 
P value with baseline <0.001 <0.001 <0.001 <0.001` <0.001 
At 4 weeks 244.67±15.71 315.21±14.09 316.49±15.16 314.68±14.91 310.73±11.98 
P value with baseline <0.001 <0.001 <0.001 <0.001 <0.001 
At 6 weeks 251.47±30.16 319.08±14.02 319.37±17.69 316.60±14.19 312.39±15.59 
P value with baseline <0.001 <0.001 <0.001 <0.001 <0.001 
At 8 weeks 259.0±29.56 328.92±11.87 325.28±16.05 324.85±13.61 320.52±15.61 
P value with baseline <0.001 <0.001 <0.001 <0.001 <0.001 
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The present study was a Hospital based prospective 
observational study conducted on 75 eyes of patients 
with type 2 diabetes mellitus with NPDR who were 
diagnosed with cataract and underwent uncomplicated 
phacoemulsification and posterior chamber intraocular 
lens implantation at ddepartment of ophthalmology of 
tertiary care teaching hospital of Southern Rajasthan. 
In our study, meancentral macular thickness (CMT) 
increased from 239.49±15.24 µm to 249.20±18.25 µm 
at 2 weeks follow up, 244.67±15.71 µm at 4 weeks 
follow-up, 251.47±30.16 µm at 6 weeks follow-up and 
259.01±29.56 µm at 8 weeks follow-up.In contrast to 
our study, Abdl-El-Khalik et al[15] reported very high 
increase of foveal thickness after cataract surgery (from 
254.88 ± 32.53 initially to 310.52 ± 64.74 at1 month) 
postoperatively in diabetic patients. This difference 
could be due to inclusion of severe diabetic retinopathy 
subjects which might shows higher increase in macular 
thickness. Another study by El-Sobkya HM et al[16] 
also reported increase in central macular thickness. In 
diabetic group, the preoperative CMT was 245 ± 57.89 
μm. At the first follow-up, the CMT mean foveal 
thickness was 300.35 ± 76.28 μm, whereas at last 
follow-up it was 250.54 ± 82.41 μm. Similarly, 
Degenring RF et al[13]and Chen XY et al[17]also 
reported significant increase in central macular 
thickness.In our study parafoveal thickness also 
showed significant increase after phacoemulsification 
compared to baseline at 2,4,6 and 8 weeks follow-up 
(<0.001). Similar to our study Chen XY et al[17] also 
observed increase in average inner ring thickness 
from314.0 µm preoperatively to 328.2 µm (post-op 
1month) to332.2 µm (post-op 3month). And the 
average outer ringthickness increased from276.5 µm 
preoperatively to 286.0 µm (post-op 1month) to 289.4 
µm (post-op 3month). However, theabsolute changes in 
thickness were mild in all measurements.Similar results 
have also been reported by Biro and Balla[18], though 
the extentof increase was pretty much the same extent 
as the accuracyof OCT measurement, the definite trend 
of increase inthickness in all quadrants makes the 
probability ofmeasurement variation unlikely. 
However, the clinicalmeaning of this increase in 
macular thickness remains to beexplored, as most 
patients with this subclinical increasemaintain good 
vision after surgery.[19]In present study, 3 (4.0%) 
study subjects developed macular oedema after 
phacoemulsification till 8 weeks follow up. In our 
study, similar to more recent studies, OCT was used to 
evaluate progression of Macular oedema following 
cataract surgery. Earlier studies, however, reported 
rates of Macular oedema progression from other 
methods; for example, one study reported the 
proportion of eyes manifesting angiographic CME was 
9% after cataract surgery using fluorescein 
angiography in people without diabetes.[4] Another 
study by Romero-Aroca reported development of 
diabetic macular oedema in 6.06% of 132 eyes on 
evaluation by fluorescein angiography and OCT 
following uneventful phacoemulsification.[8]In a 
single-centre study of 50 eyes, Kim SJ et al[3] reported 
an incidence rate of 22% of macular oedema one 
month after cataractsurgery which was very high 
compare to our study.DowlerJG et al78 also reported 
that DME progressed in ∼20–40% of eyes that 
underwent cataract surgery, but in a considerable 
percentage of these eyes the ME resolved 
spontaneously. Accordingly, these studies suggested 
that progression of DME may be classified as follows: 
a transient pseudophakic ME (Irvine–Gass syndrome) 
or a substantial progression of diabetic 
maculopathy.[20]The variability inreported progression 
rates of ME following cataract surgery in diabetic 
persons may beexplained by the lack of a unified 
definition of clinically-important progression of 
oedemaand/or different population settings or 
pathological parameters between studies.[21]Eriksson 
U et al[22]found development of clinical CME in 12% 
of diabetic eyes defined as a loss of >5letters between 
day 7 and week 6. Incidence of FA leakage was 76% in 
diabetic eyes. At 6 weeks, 44% of the diabetic eyes had 
qualitative changeson OCT. A statistically significant 
increase in thickness was observed for all three 
macular areasin both groups, part of it remaining at 6 
months. Retinal thickening had poor correlation with 
VA.FunatsuH et al[23] also showed that diabetic 
macularoedema progressed in ∼20–40% of eyes that 
underwentcataract surgery, but in a considerable 
percentage ofthese eyes the macular oedema resolved 
spontaneously. In study by Chen XY et al[17] at 1-
month follow-up postoperatively, 15 of 92 eyes met the 
criteria of newdevelopment or worsening of central-
involved DME,including 4 eyes with pre-existing 
central-involved ME but in their study, they 
adaptedand modified the concepts provided by 
DRCR.net anddefined ME based on macular 
thickness.Liu J et al[24] from a meta-analysis also 
supported our study’s findings. Overall,there was a 
statistically significant increase in CMT values in 
diabetic patients with mild tomoderate NPDR 
compared with diabetic patients without DR at 
postoperative 1month. Suchan increase was still higher 
in diabetic patients with mild to moderate NPDR at 
postoperative 3and 6 months. After cataract surgery, 
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one of the difficulties of assessing and managing ME 
arises from thefact that two clinical forms of oedema 
can be present, either alone or in combination, in this 
setting: DME and “post-surgical” or Irvine-Gass CME. 
Depending on the type of edema present, the course of 
treatment may be different. For example, CME maybe 
treated with anti-inflammatory treatments (both 
corticosteroid and non-steroidal). On the other hand, 
anti-VEGF and steroid products have increased the 
treatment options for CME. None of these treatments, 
however, have been proven definitively to have a role 
in the management of post-surgical ME.[25] The 
distinction between diabetic maculopathy and 
pseudophakic “Irvine Gass” cystoid macular oedema in 
postoperative cataract patients remains controversial. 
Pollack A et al[26]reported natural history of macular 
oedema in diabetics after cataract surgery by first 
prospective controlled trial. They found that although 
22 of the 44 patients in their study developed 
postoperative macular oedema, this settled without 
recourse to laser treatment in 11. Only five patients 
required laser treatment for clinically significant 
oedema which met the ETDRS criteria, findings which 
suggested that the early laser treatment of all diabetics 
with postoperative macular oedema was unnecessary. 
[26]Benson later proposed that laser photocoagulation 
of postoperative macular oedema in diabetic patients 
should therefore be delayed for up to 6 months to allow 
the Irvine Gass component to resolve before applying 
treatment.[27] 
Limitations 
 As previous studies revealed, DME and Irvine-
Gass cystoid macular edema(CME) both types of 
ME can occur in diabetic eyes undergoing cataract 
surgery. However, in our study, we did not 
differentiate these two types.  
 Follow-up time of only 8 weeks is another 
limitation of study. Though studies suggested that 
more than 60% ME occur at 1-month follow-up, 
there are reports that ME occur at 6months or even 
1year after surgery. Study with longer follow-up in 
the future is needed to derive a more accurate 
incidence of ME in diabetic eyes after cataract 
surgery. 
 In our study, since measurements of blood sugar, 
HbA1c, and blood pressure were not obtained 
during follow-up in this observational study, we 
cannot determine from this study whether sudden 
worsening of these features accounted for the 
results. 
 We used only OCT to detect macular oedema 
which is not a gold standard for detection. It is 
difficult to tell these two forms apart just assessing 
OCT measurements, obtaining parallel results of 
fundus fluorescence angiography may help to 
differentiate as petaloid accumulation of 
fluorescein around the fovea with staining of the 




From the observations made during the course of the 
study and considering the results & discussion of the 
present study, it was found that central and 
perifovealthickness increases in diabetic eyes after 
phacoemulsification regardless ofstages of DR. 
Clinicians should continue to maintain vigilance in 
diabetic patients after cataract extraction, and OCT 
should be used before surgery to establish baseline 
measurements which will help to assess the risk of ME 
development.Studies with large sample size and longer 
follow up are needed to assess the risk of Cystoid 
macular oedema (CSME) progression after cataract 
surgery and to see whether increase in central and 
perifoveal thickness after phacoemulsification is 
temporary or permanent because macular oedema may 
follow a benign course and any progression that is 
observed postoperatively can also represents natural 
progression rather than being a direct effect of surgery. 
Acknowledgement 
The authors are grateful to all the participants for their 




1. Kahn HA, Hiller R. Blindness caused by diabetic 
retinopathy. Am J Ophthalmol. 1974;78:58-67. 
2. Duke-Elder, Sir Steward, and Dobree, Diseases of 
the retina: Diseases of the carbohydrate 
metabolism; System of Ophthalmology; Henry 
Kimpton Publishers 2nd edn. 1967;X,408 
3. Kim SJ, Equi R, Bressler NM. Analysis of macular 
edema after cataract surgery in patients with 
diabetes using optical coherence tomography. 
Ophthalmology. 2007;114(5): 881-9. 
4. Mentes J, Erakgun T, Afrashi F, Kerci G. 
Incidence of cystoid macular edema after 
uncomplicated phacoemulsification. Ophthal-
mologica. 2003;217(6):408-12. 
5. Photocoagulation for diabetic macular edema. 
Early treatment diabetic retinopathy study report 
number 1. Early treatment diabetic retinopathy 
study research group. Arch Ophthalmol. 
1985;103(12):1796-1806. 
6. Escaravage GK Jr, Cohen KL, Patel SB, Hartnett 
ME, Armstrong BD, Janowski CM. Quantification 
International Journal of Health and Clinical Research, 2020;3(5):142-147                e-ISSN: 2590-3241, p-ISSN: 2590-325X                         
                                                             
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Agarwal et al            International Journal of Health and Clinical Research, 2020; 3(5):142-147 
www.ijhcr.com                              
                    147 
 
of macular and optic disc hyperfluorescence after 
phacoemulsification in diabetes mellitus. J 
Cataract Refract Surg. 2006;32:803–11. 
7. Browning DJ, McOwen MD, Bowen RM Jr, 
O'Marah TL. Comparison of the clinical diagnosis 
of diabetic macular edema with diagnosis by 
optical coherence tomography. Ophthalmology. 
2004;111(4):712-5. 
8. Romero-Aroca P, Fernandez-Ballart J, Almena-
Garcia M, Mendez- Marin I, Salvat-Serra M, Buil-
Calvo JA. Nonproliferative diabetic retinopathy 
and macular edema progression after 
phacoemulsification: prospective study. J Cataract 
Refract Surg. 2006;32(9):1438-44. 
9. Virgili G, Menchini F, Casazza G, Hogg R, Das 
RR, Wang X. Optical coherence tomography 
(OCT) for detection of macular oedema in patients 
with diabetic retinopathy. Cochrane Database Syst 
Rev. 2015 7;1:CD008081. 
10. Pollack A, Dotan S, Oliver M. Course of diabetic 
retinopathy following cataract surgery. Br J 
Ophthalmol. 1991;75(1):2–8. 
11. Jaffe GJ, Burton TC, Kuhn E, Prescott A, Hartz A. 
Progression of nonproliferative diabetic 
retinopathy and visual outcome after extracapsular 
cataract extraction and intraocular lens 
implantation. Am J Ophthalmol. 1992;114(4):448–
56. 
12. Benson WE, Brown GC, Tasman W, McNamara 
JA, Vander JF. Extracapsular cataract extraction 
with placement of a posterior chamber lens in 
patients with diabetic retinopathy. Ophthalmology. 
1993;100(15):730–8. 
13. Degenring RF, Vey S, Kamppeter B, Budde WM, 
Jonas JB, Sauder G. Effect of uncomplicated 
phacoemulsification on the central retina in 
diabetic and non-diabetic subjects. Graefes Arch 
ClinExpOphthalmol. 2007 ;245(1):18-23. 
14. Biro Z, Balla Z, Kovacs B. Change of foveal and 
perifoveal thickness measured by OCT after 
phacoemulsification and IOL implantation. Eye 
(Lond). 2008 ;22(1):8-12. 
15. Abd El-Khalik I. El-Saadania, Sameh S. 
Mandoura, Maged F. Laymounab. Evaluation of 
macular changes after uncomplicated 
phacoemulsification surgery in diabetic patients 
using optical coherence tomography. Menoufia 
Med J. 2018;31:289–92. 
16. El‑Sobkya HM, El‑Sebaeya AR, El‑Hagaab AA, 
Gaber NK. Evaluation of the progression of 
diabetic retinopathy after phaco-emulsification. 
Menouf Med J. 2014; 27:643–9. 
17. Chen XY, Song WJ, Cai HY, Zhao L. Macular 
edema after cataract surgery in diabetic eyes 
evaluated by optical coherence tomography. Int J 
Ophthalmol. 2016;9(1):81–5 
18. Biro Z, Balla Z. OCT measurements on the foveal 
and perifoveal retinal thickness on diabetic 
patients after phacoemulsification and IOL 
implantation. Eye (Lond). 2010;24(4):639-47. 
19. Sourdille P, Santiago PY. Optical coherence 
tomography of macular thickness after cataract 
surgery. J Cataract Refract Surg. 1999;25(2):256-
61. 
20. Dowler JG, Sehmi KS, Hykin PG, Hamilton AM. 
The natural history of macular edema after cataract 
surgery in diabetes. Ophthalmology. 1999 
;106(4):663-8. 
21. Ferris FL III, Miller KM, Glassman AR, Beck 
RW. A proposed method of logarithmic 
transformation of optical coherence tomography 
data for use in clinical research. Ophthalmology. 
2010;(117):1512–16. 
22. Eriksson U, Alm A, Bjärnhall G, Granstam E, 
Matsson AW. Macular edema and visual outcome 
following cataract surgery in patients with diabetic 
retinopathy and controls. Graefes Arch 
ClinExpOphthalmol. 2011;249(3):349-59. 
23. Funatsu H, Yamashita H, Noma H, Shimizu E, 
Mimura T, Hori S. Prediction of macular edema 
exacerbation after phacoemulsification in patients 
with nonproliferative diabetic retinopathy. J 
Cataract Refract Surg. 2002;28:1355–63. 
24. Liu J, Jones RE, Zhao J, Zhang J, Zhang F. 
Influence of Uncomplicated Phaco emulsification  
on Central Macular Thickness in Diabetic Patients: 
A Meta- Analysis. PLoS One. 
2015;10(5):e0126343. 
25. Baker CW, Almukhtar T, Bressler NM, Glassman 
AR, Grover S, Kim SJ et al. Macular edema after 
cataract surgery in eyes without preoperative 
central-involved diabetic macular edema. JAMA 
Ophthalmol. 2013;131(7):870-9. 
26. Pollack A, Leiba H, Bukelman A, Oliver M. 
Cystoid macular oedema following cataract 
extraction in patients with diabetes. Br J 
Ophthalmol. 1992;76:221–4. 
27. Benson WE. Cataract surgery and diabetic 
retinopathy. Curr Opin Ophthalmol 1992;3: 396–
400. 
 
Source of Support:Nil 
Conflict of Interest: Nil 
 
